Managing, Jade Vanity .

HRN: 14-56-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2024
CEFTRIAXONE 1G (VIAL)
11/03/2024
11/10/2024
IV
2 Grams
Q24 Hrs
T/c Acute Appendicitis; PCAP B
Waiting Final Action 
11/03/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/03/2024
11/10/2024
IV
250
Q8h
T/c Acute Appendicitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: